Related Experiment Videos
Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
The Journal of Pharmacology and Experimental Therapeutics
|September 1, 1983
Summary
Arylsulfatase enzyme treatment alters mouse vas deferens responses to certain opiates, suggesting complex opioid receptor interactions beyond simple binding. This impacts understanding of drug efficacy and opioid signaling pathways.
Area of Science:
- Pharmacology
- Biochemistry
- Neuroscience
Background:
- Opioid receptors mediate the effects of endogenous and exogenous opioids.
- The mouse vas deferens is a common model for studying opioid pharmacology.
- Enzymatic modification of tissues can reveal insights into drug-receptor interactions.
Purpose of the Study:
- To investigate the effect of arylsulfatase on the mouse vas deferens' response to various opiates.
- To elucidate the complexity of opioid receptor activation and signaling.
Main Methods:
- Treatment of isolated mouse vas deferens with arylsulfatase (E.C. 3.1.6.1).
- Assessment of dose-response curves for various opioid agonists (enkephalins, FK33824, levorphanol, normorphine, etorphine, beta-endorphin, dynorphin, morphine).
- Analysis of IC50 values, curve slopes, and naloxone antagonism.
Main Results:
- Arylsulfatase increased IC50 values and altered slopes for enkephalins and analogs.
- FK33824, levorphanol, and normorphine dose-response curves shifted rightward.
- Morphine exhibited a biphasic effect, while etorphine, beta-endorphin, and dynorphin were unaffected.
- Morphine's altered response was irreversible and less sensitive to naloxone compared to enkephalins.
Conclusions:
- Opioid effects in the mouse vas deferens are more complex than simple receptor occupation.
- Evidence suggests multiple functional receptor types or a single receptor with complex drug interactions.
- Findings support theories involving fractional occupancy, positive cooperativity, or multiple receptor sites.